SOURCE: Daxor Corp.

Daxor Corp.

June 16, 2011 08:54 ET

Daxor Announces that Hartford Hospital of Hartford, CT Acquires BVA-100 Blood Volume Analyzer

NEW YORK, NY--(Marketwire - Jun 16, 2011) - Daxor Corporation (NYSE Amex: DXR), a medical instrumentation and biotechnology company, today announced the receipt of a signed trial agreement from Hartford Hospital of Hartford, Connecticut. This will provide Hartford Hospital with a Blood Volume Analyzer-100 (BVA-100), an instrument which enables semi-automated measurement of a patient's total blood volume, red blood cell volume and plasma volume. Blood volume abnormalities are observed in a variety of cardiac conditions and have been associated with poor prognosis.

Hartford Hospital will be participating in a multi-center clinical trial (TEAM-HF) which will test whether incorporation of blood volume assessments into treatment decisions can improve the care and outcomes of patients with heart failure. Dr. Detlef Wencker, director of the heart failure and transplant center, will serve as the local Principal Investigator, and will be joined by Drs. Joseph Radojevic and Jason A. Gluck to conduct the study at Hartford Hospital. The objective of the interventional TEAM-HF Study is to determine whether correcting any identified blood volume abnormalities in heart failure patients leads to decreased hospitalization and mortality, and an improvement in exercise capacity and quality of life. This trial will enroll 300 heart failure patients from 11 medical centers.

Hartford Hospital is an 867-bed regional referral center providing high-quality care in all clinical disciplines. The hospital's major centers of clinical excellence include cardiology, oncology, emergency services and trauma, mental health, women's health, orthopedics, bloodless surgery and advanced organ transplantation. Hartford Hospital owns and operates the state's only air ambulance system, LIFE STAR.

Hartford Hospital is part of Hartford HealthCare ("HHC"), which is focused on becoming the next generation of integrated health systems, marked by strong patient focus, heightened efficiency, focus on research, consistent quality performance and open, collaborative sharing of best practices.

The HHC system includes MidState Medical Center; Windham Hospital; The Hospital of Central Connecticut, The Institute of Living psychiatric center; VNA HealthCare; VNA Central Connecticut; Clinical Laboratory Partners; Hartford Medical Group; Eastern Rehabilitation Network; and two regional behavioral health centers: Rushford and Natchaug Hospital.

Daxor Corporation manufactures and markets the BVA-100, which is used in conjunction with Volumex, Daxor's single use diagnostic kit. For more information regarding Daxor Corporation's Blood Volume Analyzer BVA-100, visit Daxor's website at www.Daxor.com.

Contact Information

  • Contact Information:
    Stephen Feldschuh
    Chief Operating Officer
    212-330-8500
    stephen@daxor.com
    or
    Diane Meegan
    Investor Relations
    212-330-8512
    dmeegan@daxor.com

    Michaela Donnelly
    Hartford Hospital Media Relations
    860-545-4658